Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Mar 19, 2020 · 10-K · 79 days after period end · 0001564590-20-011712
| Metric | Q4 2019 | Q4 2018 |
|---|---|---|
| Net Income | -$98.01M | -$484.00K |
| EPS Diluted | -$3.97 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 19, 2020 · 79 d after period end
